Harnessing the Power of Proteomics

Global commercial and technological leader for bio-pharma and clinical protein discovery, measurement and interpretation.

CM Life Sciences II Merger Announcement

SomaLogic, Leading AI-Data Driven Proteomics Platform for Advanced Research and Clinical applications, to Combine with CM Life Sciences II, to Drive Growth and Expand Technology Platform.

CM Life Sciences II Inc., Sponsored by Affiliates of Casdin Capital and Corvex Management, Announces Pricing of Upsized $240 Million Initial Public Offering

CM Life Sciences II Inc. (the “Company”) announced today that it priced its initial public offering of 24,000,000 units at $10.00 per unit. 

Final Prospectus

As filed with the Securities and Exchange Commission

SEC Filings

Link to all items filed with the Securities and Exchange Commission